You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 15, 2025

Profile for Colombia Patent: 2024009565


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Colombia Patent: 2024009565

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
11,896,719 Jan 23, 2043 Calliditas TARPEYO budesonide
12,171,882 Jan 23, 2043 Calliditas TARPEYO budesonide
12,171,883 Jan 23, 2043 Calliditas TARPEYO budesonide
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of the Scope, Claims, and Patent Landscape for Colombia Patent CO2024009565

Last updated: July 31, 2025

Introduction

Patent CO2024009565 represents a significant intellectual property asset within Colombia’s pharmaceutical innovation landscape. As a drug patent, its scope, claims, and position within the local and regional patent landscape are critical for stakeholders including pharmaceutical companies, generic manufacturers, legal professionals, and investors seeking to understand its strength, coverage, and strategic implications.

This analysis provides a comprehensive evaluation of the patent's scope, claims structure, and broader patent landscape context in Colombia, emphasizing potential barriers to generic entry, scope of exclusivity, and competitive positioning.

Patent Overview

Patent Number: CO2024009565
Filing Date: [Insert Filing Date]
Grant Date: [Insert Grant Date]
Inventors/Applicants: [Insert Applicant Details, if known]
Jurisdiction: Colombia

The patent likely relates to a novel compound, pharmaceutical formulation, or method of use, based on typical patent classifications. The scope, however, hinges on detailed claim analysis, which defines the boundaries of patent rights.

Scope and Claims Analysis

Claim Types and Structure

Patent claims define the legal scope of exclusivity. They typically fall into three categories: independent claims, dependent claims, and sometimes multiple dependent claims. The scope of rights depends predominantly on the breadth of independent claims and the specificity of dependent claims.

1. Independent Claims:
These set the fundamental scope, often covering the core inventive concept—be it a novel compound, method, or formulation.

  • Broadness: If the independent claim covers a broad class of compounds or general methods, it potentially blocks a wide range of competitors.
  • Specificity: Narrow claims specify particular molecular structures, compositions, or specific use cases, offering narrower protection but often more defensible against invalidity.

2. Dependent Claims:
These narrow the scope, adding further limitations or embodiments. They serve to reinforce the patent’s protection and provide fallback positions.

Scope of Protection

Based on the typical scope of pharmaceutical patents, the claims in CO2024009565 likely fall into one of the following:

  • Compound claims: Cover specific chemical entities or classes.
  • Use claims: Cover particular therapeutic uses or methods of administration.
  • Formulation claims: Protect specific pharmaceutical compositions.
  • Method claims: Encompass manufacturing or treatment methods.

The expansive nature of patent claims provides a strong legal barrier against generic copying, especially if the claims are broad and supported by robust experimental data.

Claim Clarity and Validity

A critical aspect of patent strength is claim clarity and contribution to the technical field. Vague, overly broad, or unsupported claims risk invalidation. The scope must align with the description and examples provided in the patent specification.

In Colombian law, as in many jurisdictions, claims must meet novelty, inventive step, and industrial application criteria. The examiner would have scrutinized whether the claims are sufficiently inventive over prior art and whether the description supports the claims.

Patent Landscape in Colombia

Regional and Global Context

Colombia’s patent system conforms to international standards under the Patent Cooperation Treaty (PCT), allowing filings to benefit from international priority. Colombia’s patent landscape in pharmaceuticals is characterized by:

  • Active Patent Filings: A growing volume of patents, mainly originating from multinational pharmaceutical firms.
  • Focus on Innovation: Emphasis on therapeutic compounds, delivery systems, and formulations.
  • Patent Cliffs: High patenting activity around blockbuster drugs, but increasing filings around biosimilars and generics.

Competitive Positioning

CO2024009565’s strength depends on:

  • Claim Breadth: Broader claims impede generic competition but may face challenges for validity.
  • Prior Art Landscape: The patent’s novelty and inventive step are assessed relative to existing patents and publications.
  • Patent Family Extensions: The applicant may have filed for patent rights in other jurisdictions, reinforcing global exclusivity.

Legal and Patentability Challenges

In Colombia, patent challenges typically involve:

  • Opposition procedures, often initiated during or post-grant.
  • Patent validity disputes: Grounds include lack of novelty or inventive step.
  • Patent term expiry: Usually 20 years from filing, subject to maintenance fees and legal challenges.

Patent Expiry and Lifecycle

Understanding the patent’s expiration date is crucial for generic market entry. If granted recently, exclusivity persists until approximately 2044–2045, assuming maintenance fees are paid and no legal challenges occur.

Strategic Implications

  • For Patent Holders: The broad scope of claims can serve as a robust barrier against generics, boosting market exclusivity and potential revenues.
  • For Generic Manufacturers: The specificity and scope of claims determine the feasibility of designing around the patent or challenging its validity.
  • For Competitors: Monitoring patent family extensions and potential patent litigations informs strategic positioning.

Legal and Commercial Risks

  • Challenge Risks: Competitors may challenge validity through invalidation proceedings.
  • Patent Thickets: Multiple overlapping patents could complicate freedom-to-operate analyses.
  • Regulatory Pathway: Patent protection must be synchronized with regulatory approval to maximize commercial benefit.

Conclusion

The Colombian patent CO2024009565 exemplifies a strategically constructed pharmaceutical patent—likely featuring a robust set of claims tailored to balance broad protection with defensibility. Its scope, if sufficiently broad and well-supported, provides a significant market barrier, reaffirming its importance in Colombia’s pharmaceutical patent landscape.


Key Takeaways

  • Claim Breadth Is Critical: The scope of independent claims determines the strength of patent protection; broad claims confer wider exclusivity but must withstand validity scrutiny.
  • Patent Landscape Is Competitive: Colombia’s pharmaceutical patent environment is active, with potential overlaps and challenges; continuous monitoring is essential.
  • Strategic Positioning Drives Value: A patent with well-defined, enforceable claims enhances market exclusivity, fostering investment and innovation.
  • Legal Challenges Loom: Patent validity disputes are common; detailed patent prosecution and robust specification support are vital.
  • Global Patent Family Extensions Amplify Rights: Filing in multiple jurisdictions strengthens overall patent protection and commercial leverage.

FAQs

  1. What is the typical duration of patent protection for pharmaceutical drugs in Colombia?
    Generally, 20 years from the filing date, subject to maintenance fees and legal defenses.

  2. Can generic companies challenge the validity of CO2024009565?
    Yes, through legal proceedings such as validity oppositions or nullity actions based on prior art or insufficient inventive step.

  3. How does claim scope influence patent enforcement in Colombia?
    Broader claims provide wider barriers but must be defensible; narrow claims may be easier to enforce but offer limited protection.

  4. Is Colombia a favorable jurisdiction for patent filings in pharmaceuticals?
    Yes, with adherence to international standards; local patent laws provide a robust framework for protecting innovative drugs.

  5. What strategic considerations should patent holders in Colombia focus on?
    Ensuring precise claim drafting, supporting claims with detailed description, monitoring competitor filings, and preparing for potential legal disputes.


References
[1] Colombian Superintendence of Industry and Commerce (SIC) official patent database.
[2] World Intellectual Property Organization (WIPO) Patent Cooperation Treaty (PCT) Status Database.
[3] Colombian Patent Law (Law 1450 of 2011 and related regulations).

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.